Marinol and Ergocalciferol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Marinol (dronabinol) and Ergocalciferol (ergocalciferol). Common drug interactions include fall among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Marinol and Ergocalciferol. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Marinol?

Marinol has active ingredients of dronabinol. It is often used in pain. eHealthMe is studying from 4,963 Marinol users. Check the latest studies of Marinol.

What is Ergocalciferol?

Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.



On Jul, 13, 2026

26 people who take Marinol and Ergocalciferol together, and have interactions are studied.

Marinol and Ergocalciferol drug interactions.

What are the common drug interactions of Marinol and Ergocalciferol, by gender? *:

female:

  1. Fall
  2. Fatigue (feeling of tiredness)
  3. Fluid retention (an abnormal accumulation of fluid in the blood)
  4. Fungal skin infection
  5. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  6. Heart rate increased
  7. Hypoglycaemia (deficiency of glucose in the bloodstream)
  8. Hypotension (abnormally low blood pressure)
  9. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  10. Oedema (fluid collection in tissue)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Emotional distress
  3. Plasma cell myeloma (cancer that begins in plasma cells)
  4. Abdominal abscess (collection of pus in abdomen)
  5. Acute chest syndrome (acute chest pain, fever and difficulty breathing)
  6. Adhesion
  7. Alopecia (absence of hair from areas of the body)
  8. Arthralgia (joint pain)
  9. Back pain
  10. Blindness unilateral

What are the common drug interactions of Marinol and Ergocalciferol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Adhesion
  2. Anaemia (lack of blood)
  3. Dehydration (dryness resulting from the removal of water)
  4. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  5. Ileus (a painful obstruction of the ileum or other part of the intestine)
  6. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  7. Intestinal stenosis (partial obstruction that causes the centre opening of the intestine to become narrower)
  8. Abdominal abscess (collection of pus in abdomen)

30-39:

n/a

40-49:

  1. Dizziness
  2. Pneumonia
  3. Abdominal pain
  4. Adverse event
  5. Agitation (state of anxiety or nervous excitement)
  6. Arterial haemorrhage
  7. Asthma
  8. Balance disorder
  9. Blood pressure decreased
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Bone density decreased
  3. Chronic kidney disease
  4. Emotional distress
  5. Abdominal pain
  6. Osteoporosis (bones weak and more likely to break)
  7. Renal disorder (kidney disease)
  8. Renal impairment (severely reduced kidney function)
  9. Alanine aminotransferase increased
  10. Aspartate aminotransferase increased

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Pain in extremity
  3. Candida pneumonia (infection of lung by candida)
  4. Decreased appetite
  5. Disease progression
  6. Eye infection
  7. Fatigue (feeling of tiredness)
  8. Fluid retention (an abnormal accumulation of fluid in the blood)
  9. Fungal skin infection
  10. Headache (pain in head)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 6 people, 23.08%
  2. Hiv Infection: 5 people, 19.23%
  3. Constipation: 3 people, 11.54%
  4. Vitamin D Decreased: 2 people, 7.69%
  5. Nausea And Vomiting: 2 people, 7.69%
  6. Multiple Myeloma (cancer of the plasma cells): 2 people, 7.69%
  7. Indigestion: 2 people, 7.69%
  8. Immunodeficiency Common Variable: 2 people, 7.69%
  9. Hyperkalemia (damage to or disease of the kidney): 2 people, 7.69%
  10. Hodgkin's Lymphoma (cancer originating from white blood cells): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Marinol and Ergocalciferol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Marinol and Ergocalciferol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Marinol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ergocalciferol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Marinol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ergocalciferol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on dronabinol and ergocalciferol (the active ingredients of Marinol and Ergocalciferol, respectively), and Marinol and Ergocalciferol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: